A study in healthy men to test how BI 1839100 is taken up and handled by the body
This study is for healthy men and is designed to understand a new medicine called BI 1839100. Researchers want to see how the body takes up this medicine, how it processes it, and how it gets rid of it. This is a very early stage of testing new medicines, often called a Phase I study. It helps scientists learn important safety information and how the medicine behaves in people before it can be tested in patients who have a specific illness. By taking part, you would be helping researchers gather crucial information about this new medicine, contributing to future medical advancements. It is not designed to treat a specific health problem, but to increase our understanding of the drug itself.
At a glance
What is this study about?
Imagine scientists are building a new type of car and want to understand how it handles on the road. This study is a bit like that, but for a new medicine called BI 1839100. Researchers want to see how this medicine behaves once it's inside a person's body. They'll be looking at things like how much of it gets absorbed, where it goes, how the body changes it, and how it eventually leaves the body. This information is really important because it helps them understand the right dose to use and if the medicine is likely to be safe.
This type of study is one of the very first steps when a new medicine is being developed. It's called a 'Human Pharmacology' study, or often a 'Phase I' study. This means it's usually done in a small number of healthy volunteers, not people with a specific illness. The main goal is to gather basic facts about the medicine's safety and how it works in the body, rather than treating a disease.
Taking part in studies like this is really valuable. It allows researchers to learn about new medicines in a carefully controlled way. The information gathered helps decide if a medicine can move forward to later stages of testing, where it might eventually help people who are unwell. Without volunteers, new medicines could not be developed.
Key takeaways
- A study for healthy men aged 18 and over.
- Aims to understand how a new medicine, BI 1839100, works in the body.
- This is an early-stage (Phase I) study, focusing on safety and how the medicine behaves.
- Participation involves health checks, taking the study medicine, and regular monitoring.
- Helps advance medical knowledge for future treatments.
- You have the right to withdraw from the study at any time.
Who may be eligible?
This study is specifically looking for healthy men to take part. To be considered, you must be an adult, aged 18 years or older. There isn't an upper age limit mentioned, but you would still need to meet all other health requirements.
Being 'healthy' means you don't have any serious ongoing medical conditions, and you're not taking certain medications that might interfere with the study. The research team will do a thorough health check to make sure participating is safe for you.
They are only looking for men because sometimes medicines can affect men and women differently, and they might want to study one group first to get clear results.
- Are you a man?
- Are you 18 years old or older?
- Do you consider yourself generally healthy?
- Do you not have any major ongoing medical conditions?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part, you would first have a screening visit. This is when the study team checks your health to make sure the study is right for you. This might involve a physical exam, blood tests, and checking your medical history.
If you're eligible, you will receive the study medicine, BI 1839100. This is likely given in a controlled setting, and you would be monitored closely. There will be several study visits, possibly including an overnight stay or stays, where doctors and nurses will take measurements like blood samples, check your heart, and ask about how you are feeling to see how the medicine is affecting your body.
After you have received the medicine, there would be follow-up visits or phone calls to make sure you remain well. The total duration of your involvement could vary, but these early-stage studies often involve a few weeks or months from your first screening appointment to your final follow-up.
Potential risks and benefits
Locations (1)
- —Netherlands
Common questions
What is BI 1839100?
BI 1839100 is a new medicine that is being tested for the first time in people. Researchers want to understand how it works in the body.
Why do you need healthy volunteers?
Healthy volunteers help researchers understand how a new medicine behaves in a healthy person's body before giving it to people with an illness. This helps make sure it's safe.
Will this medicine treat any illness I have?
No, this study is not designed to treat any particular health problem. It's about learning how the medicine works in the body, not about curing a disease.
What if I feel unwell during the study?
The study team will monitor you closely. If you feel unwell, you should tell them immediately. Your safety is their top priority.
Will I get paid to take part?
Some studies offer payment for your time and travel, but this would be clearly explained to you before you agree to take part. It would not be considered payment for risks.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.